Mitsubishi Tanabe Pharma Corporation (MTPC), our parent company based in Japan, sponsors research projects into the following different therapeutic areas:
- Autoimmune Diseases
- Diabetes and Kidney Diseases
- Central Nervous System Diseases
Mitsubishi Tanabe Pharma Europe (MTPE) focus on studies in the earlier phase of clinical development including healthy volunteer studies. Patient studies are also performed in support of the development pipeline.
Currently MTPE is supporting the development of compounds in the following disease areas:
- Diabetic Nephropathy
- Diabetic Neuropathy
- Nonalcoholic Steatohepatitis (NASH)
- Vasomotor Symptoms (VMS - hot flashes in peri- or post-menopausal women)
If you would like further information on the patient studies in the above disease areas, please click here and follow the links.